BayernKapital

Bayern Kapital, founded in 1995 and based in Landshut, Germany, is a key venture capital firm focused on supporting high-tech startups and scale-ups in Bavaria. With nearly 30 years of experience, the firm manages around €700 million and has invested in over 320 Bavarian high-tech companies. Bayern Kapital offers investments ranging from €250,000 to €25 million per company, targeting sectors such as biotechnology, medical technology, software and IT, environmental technology, and new materials. The firm's investment approach emphasizes long-term partnerships, acting as a co-investor alongside private investors to support startups through various growth phases from seed to scale-up. Bayern Kapital prides itself on fostering innovation and entrepreneurship in Bavaria, aiming to drive job creation and economic development in the region. Some notable investments in their portfolio include companies like ProGlove, Immunic Therapeutics, and Sphera. Bayern Kapital's strategy is to offer not just financial support but also leverage their extensive network to help startups connect with potential investors, partners, and customers, thereby enhancing their growth prospects. Key team members include Wolfgang Härtl, Investment Director, who leads their dedicated team of over 40 professionals with diverse academic and professional backgrounds, contributing to their robust support system for portfolio companies​.